Medicine and Dentistry
Adenocarcinoma
24%
Adenocarcinoma in Situ
18%
Alpha-Fetoprotein
21%
Atypical Hyperplasia
57%
Axillary Lymph Node
15%
Biological Marker
25%
Biopsy
33%
Breast Cancer
16%
Breast Carcinoma
21%
Cancer
17%
Carcinoid
19%
Carcinoma
38%
Catenin
36%
CD8 Antigen
29%
Clear Cell Carcinoma
16%
Dentigerous Cyst
15%
Diagnosis
54%
Endodermal Sinus Tumor
24%
Endometrioid Carcinoma
28%
Endometriosis
29%
Endometrium Carcinoma
45%
False Positive Result
24%
Fine-Needle Aspiration
24%
Germinoma
14%
Glypican 3
21%
Immunohistochemistry
44%
Intraepithelial Neoplasia
36%
Lung Tumor
18%
Lymph Node Metastasis
14%
Macrophage
15%
Metastatic Carcinoma
42%
Morphology
23%
Mucinous Carcinoma
16%
Neoplasm
100%
Overall Survival
16%
Pathologist
17%
Precancerous Condition
49%
Prevalence
20%
Programmed Death-Ligand 1
36%
Prostate Adenocarcinoma
24%
Prostate Specific Antigen
18%
Protein Expression
15%
Recurrent Disease
12%
Sentinel Lymph Node
26%
Serous Carcinoma
36%
Triple Negative Breast Cancer
24%
Tumor Cell
35%
Tumor Infiltrating Lymphocyte
29%
Tumor Invasion
15%
Uterine Cervix
14%
Keyphrases
Alkaline Phosphatase
12%
Atypical Hyperplasia
26%
B7-H3
12%
Benign Glandular Inclusion
12%
Breast
24%
C-cell Hyperplasia
12%
Carcinoma in Situ
24%
CD10
12%
CD8+ Tumor-infiltrating Lymphocytes
13%
Co-expression
12%
Combined Positive Score
23%
Cytokeratin 5
12%
Dako
12%
Decalcification Agent
12%
Distant Metastasis
24%
DPC4
12%
Early Detection
14%
Endometrial Carcinoma
20%
Endometrial Precancer
24%
Epithelial Malignant Tumor
12%
EVALI
12%
Expression Level
13%
Extragonadal Yolk Sac Tumor
12%
Glomangioma
12%
High Risk
14%
Immunohistochemical Markers
13%
Immunohistochemical Study
12%
Kidney
12%
Lymph Node Sampling
12%
Metastatic Prostatic Adenocarcinoma
12%
Mismatch Repair Genes
12%
Mucinous Adenocarcinoma
12%
Nodal Metastasis
12%
Oil Red O
12%
Ovarian Endometriotic Cyst
12%
Papanicolaou
12%
Pathologist
13%
Patient Cohort
12%
PD-L1 Expression
15%
Primitive Germ Cell Tumors
13%
Programmed Death-ligand 1 (PD-L1)
24%
Protein Expression
13%
Risk Subset
12%
Routs
12%
Triple-negative Breast Carcinoma
24%
Tumor
21%
Tumor Cells
20%
Tumor Proportion Score
15%
Urothelial Malignancy
12%
Ventana
12%